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Results from twin studies examining the genetic overlap between type 2 diabetes and 
depression are currently inconclusive.  This question has not been addressed in non-western 
populations.  We aimed to examine whether there are common genetic factors between type 2 
diabetes and depression in a Sri-Lankan population, using genetic model-fitting analysis. 
 
Method 
The Colombo Twin and Singleton Study-Phase 2 consists of 2019 singletons, 842 
monozygotic and 578 dizygotic twin-pairs. The primary outcomes were self-reported type 2 
diabetes diagnosis and Beck Depression Inventory scores. Standard bivariate twin models 




In the best-fitting model, the phenotypic correlation between type 2 diabetes and depression 
was significant in females only (r=0.15 (0.08-0.21)). This association was primarily attributed 
to a significant genetic correlation between the traits (rA=0.53 (0.19-0.98)). 
 
Conclusions 
In females, but not males, we found a significant genetic overlap between type 2 diabetes and 
depression in the context of a modest phenotypic correlation. 
 







Type 2 diabetes (T2DM) and depression are common disorders with considerable impact at 
personal, societal and national levels.  An association between T2DM and depression is well 
documented in epidemiological studies, with up to 60% increased risk for developing T2DM 
in individuals with depression and 15% for incident depression in those with T2DM alone 
(1,2). Depression is significantly associated with suboptimal glycaemic control, higher 
complication rates and increased mortality in people with T2DM (3–5). In addition, systemic 
inflammation, hypercortisolism and disturbed immune functions have been demonstrated to 
contribute to the T2DM-depression association (6–8).  Similar neuroimaging changes in 
white and grey matters have been observed in both people with T2DM and depression (9). 
There is now increasing evidence for common biological mechanisms being at play in the 
causal pathway for both T2DM and depression (10). It is therefore plausible that genetic 
pleiotropy between T2DM and depression might also explain some of the comorbidity 
observed. Furthering our understanding of the underlying mechanism of the T2DM-
depression association will allow us to develop treatments and improve outcomes in this 
high-risk comorbid group.  
 
Four twin studies have examined the genetic overlap between T2DM and depression.  Two 
studies reported no evidence of correlated genetic factors (11,12), whereas qualitative and 
quantitative sex differences were reported in the (genetic) association of T2DM and 
depression in two large Scandinavian populations (13).  Two studies using a polygenic score 
approach (14,15) and two studies using a linkage disequilibrium score approach (16,17) in 
genome-wide association studies (GWAS) have, however, reported no evidence of a genetic 
overlap between T2DM and depression.  These studies were conducted in Western 






genetic perspective was conducted collectively in six ethnic groups, namely East Asian, 
South Asian, European, African, Latin American and Native North American (14).  Although 
the association between T2DM and depression has been observed in non-western populations 
(18–20), its genetic determinants have yet to be examined and there are reasons to suggest 
that these might be different.  In addition, the point prevalence of depression has been 
reported to vary with the human development index  (21) whereas the prevalence of T2DM in 
non-western populations is rapidly increasing, with a younger age of onset and greater 
mortality, in comparison to western populations (22). Furthermore, previous twin studies 
have raised the possibility that the genetic architecture of depression might be different in 
non-western populations, especially in males (23).  To further complicate the picture, 
epidemiological studies in Western populations have reported substantially higher prevalence 
rate of comorbid T2DM and depression in females compared with males (24–26).  A genetic 
model incorporating possible quantitative and qualitative sex differences in genetic and 
environmental effects is therefore called for.  In this study, we aimed to examine the genetic 
overlap of T2DM and depression in a South-Asian (Sri-Lankan) twin population sample 




The Colombo Twin and Singleton Study (CoTaSS) is a population based sample of twins and 
a comparable sample of non-twins (singletons) born in the Colombo district of Sri Lanka, 
with >90% participation rate (23). CoTaSS-2 is a follow up of the original study and was 
conducted between 2012 and 2014, with >75% participation rate (83% in twins; 62% 
singletons) (27).  In brief, CoTaSS-2 was designed to examine the relationship between 






participants. Demographic and phenotypic data were collected through extensive healthcare 
questionnaires whereas anthropometric and biological data were collected by trained research 
assistants.  The study received ethical approval from the Psychiatry, Nursing and Midwifery 
Research Ethics Subcommittee at King’s College London (UK; reference number: 
PNM/10/11-124) and the Faculty of Medical Sciences Ethical Review Committee at 
University of Sri Jayewardenepura (Sri Lanka; reference number: 596/11). 
 
Outcome variables  
T2DM was defined as the presence of type 2 diabetes as reported by the participants.  In 
addition, fasting blood glucose and Hba1c (glycated haemoglobin) levels were collected 8 
months after participants were recruited into the study.  Depression was measured using the 
Beck Depression Inventory (BDI) which captures depressive symptoms and severity in the 
past two weeks (28). The BDI was translated into Sinhalese by a panel of clinical 
professionals fluent in both Sinhalese and English. The BDI questionnaire was cross-
culturally adapted in wording in order to best describe the questions in their meaning (29) and 
has been previously been validated in the Sri Lankan population (23).  Secondary variables 
included self-reported age and sex.  Zygosity of same-sex twin pairs was based on a standard 
self-report questionnaire measure of similarity (30).   
 
Statistical Analysis 
The classical twin method builds on the following three main assumptions: i) monozygotic 
(MZ) twins share 100% and dizygotic (DZ) twins share on average 50% of their segregating 
genes [additive genetic effects]; ii) MZ and DZ twins are correlated for environmental 
influences to the same extent [equal environment assumption] and iii) mating in the 






differences in a trait are assumed to arise from: additive genetic (A), common environmental 
(C) and unique environmental (E) influences.  In a bivariate ACE model, in addition to the A, 
C and E components of each trait, the phenotypic correlation between two traits can be 
partitioned into correlating addictive genetic (rA), shared environmental (rC) and unique 
environmental (rE) effects (31).  Having same-sex male and female MZ and DZ twin pairs as 
well as opposite-sex twin pairs, allows testing for: i) “qualitative sex differences” where 
different genetic and common environmental factors are involved in males and females; and 
ii) “quantitative sex differences” where the same genetic and environmental factors are 
involved but the magnitude of their effect is modulated by sex.  The power to estimate 
qualitative sex differences is based on differences of within-trait and cross-trait correlations 
in opposite-sex DZ pairs compared to same-sex DZ pairs, whereas the power to estimate 
quantitative sex differences is based on differential MZ and DZ within-trait and cross-trait 
correlations in same-sex twin pairs.   
 
A full sex-limitation model was first fitted in which the A, C and E parameters were allowed 
to differ between males and females, allowing to test for quantitative sex differences.  In 
addition, for opposite-sex pairs, the correlations between the A factors and the C factors 
between males and females were estimated freely in succession.  These two models were then 
compared to the model in which the correlations between the A factors were constrained to 
0.5 and those between the C factors to 1 in opposite-sex pairs respectively.  This allows us to 
test for qualitative sex differences. Equating the male and female parameters allows us to test 
for quantitative sex differences. The software programme OpenMx (32) was used for genetic 
model-fitting analysis on combined dichotomous T2DM data and continuous, log-
transformed sex-and age-regressed BDI residual scores.  Age effects on T2DM were 






Two criteria were used to choose the best fitting model: i) differences in minus twice the log-
likelihood (-2LL) distributed as chi-square and ii) Akaike’s Information Criterion (AIC) (33), 
with lower values indicating a better balance between explanatory power and parsimony and 





The CoTASS-2 sample used in this analysis consisted of 3956 twin individuals (1963 twin 
pairs and 30 twin individuals) and 2019 singletons.  Of the twin individuals, 42.8% was MZ, 
29.8% was same-sex DZ and 27.4% was opposite-sex DZ (table 1).  The mean age was 43.0 
(standard deviation (SD): 14.3)) and mean BMI was 23.8 kg/m
2
 (SD: 4.6).  There were 471 
cases with self-reported T2DM in total.  For the entire sample, the mean fasting plasma 
glucose was 6.0 mmol/l (SD: 2.3).  The mean HbA1c was 42.1 mmol/mol (SD: 15.3) as per 
International Federation of Clinical Chemistry (IFCC) units and 6.0% (SD: 1.4) as per 
Diabetes Control and Complications Trial (DCTT) units. The intra- and inter-assay 
coefficient of variations for HbA1c was 0.6 and 2.66 from set 1 and 0.32 and 2.61 from set 2 
respectively.  For individuals with a self-reported diagnosis of T2DM, the mean fasting 
plasma glucose was 8.9 mmol (SD: 4.3) and mean HbA1c was IFCC: 3.8 mmol/mol (SD: 
47.0; DCTT: 8.9% (SD: 4.3)).  For individuals who did not report a diagnosis of T2DM, the 
mean fasting plasma glucose was 5.6 mmol/l (SD: 1.4) and mean HbA1c was 38.8 mmol/mol 
(SD: 9.8; DCTT: 5.7% (SD: 0.9)). 
 
The recommended diagnostic cut-off for T2DM using HbA1c is IFCC: ≥48mmol/mol (DCTT: 






reported T2DM and for whom biological samples were available (n=426), 320 (75.1%) had 
either/both HbA1c and fasting plasma glucose above diagnostic cut-offs (figure 1).  Both 
HbA1c and fasting plasmas glucose can be within the normal range among people with well-
controlled T2DM and therefore, does not exclude T2DM being present.  Among individuals 
who did not report having a T2DM diagnosis and for whom biological samples were 
available (n=2966), 244 (8.2%) had either/both HbA1c and fasting plasma glucose above 
diagnostic cut-offs (figure 1).  This suggests there might be a small proportion of individuals 
in CoTaSS-2 who fulfil the diagnostic criteria for T2DM but are unaware of the disease 
process. 
 
The mean BDI depression score was 4.9 (SD: 6.2; Cronbach’s α=0.87), with 355 
individuals (9.2%) scoring above 13, the cut-off for a clinical diagnosis of depression 
using the BDI.   The BDI scores were positively skewed on visual inspection, with a 
kurtosis of 6.98 which reduced to -0.17 after log-transformation of the age and sex-
regressed scores. In males, the phenotypic correlations between depression and i) self-
reported T2DM diagnosis, ii) fasting blood glucose and iii) Hba1c were 0.06 (95% 
confidence interval: -0.02-0.14), 0.06 (0-0.11) and 0.06 (0.01-0.11) respectively.  In 
females, they were 0.15 (0.08-0.21), 0.05 (0.01-0.10) and 0.06 (0.01-0.10).  Correlations 
stratified by zygosity and sex are summarised in table 2.  Given the small phenotypic 
correlation between depression and both fasting blood glucose and Hba1c, we focused on 
the genetic model-fitting between depression and self-reported diagnosis of T2DM. 
 
Genetic model-fitting  
First, a sex-limitation ACE model including quantitative and qualitative genetic sex 






qualitative genetic sex differences was tested by comparing this model to one in which the 
correlation between the A and C factors across males and females in opposite-sex pairs were 
constrained to correlate at 0.50 and 1 respectively, as is the case in same-sex DZ pairs 
(HetACE: -2LL=15432.42; df=7803; AIC=-174.58).  This resulted in a non-significant 
decline in model-fit (HetACEg vs. HetACE: χ
2
(df=4)=1.52; p=0.82), indicating that qualitative 
sex differences for the genetic factors were negligible.  Secondly, a sex-limitation ACE 
model including quantitative and qualitative common environmental sex differences was 
fitted (HetACEc: -2LL=15431.33; df=7799; AIC=-166.67).  Compared to the HetACE 
model, this model also showed a non-significant decline in fit (HetACEc vs. HetACE: 
χ
2
(df=4)=0.097; p>0.99).   Thirdly, we tested for quantitative sex differences by equating the A, 
C and E parameters across males and females (HomoACE: -2LL=15583.57; df=7812; AIC=-
40.43).  Compared to the HetACE model this resulted in a significant decline in fit 
(HomoACEc vs. HetACE: χ
2
(df=9)= 152.15; p<0.0001), indicating some importance of 
quantitative sex differences. The best-fitting sex-limitation model with quantitative sex 
differences only is represented in figure 2.  
 




) and unique 
environment (e
2
) variance of the traits were similar across sexes for T2DM: 82% (31%-98%), 
12% (0%-61%) and 6% (2%-17%) respectively in males, and 77% (34%-94%), 8% (0%-
31%) and 15% (6%-29%) respectively in females.  For depression, the estimates are different 
across sex for depression: 7% (0%-29%), 22% (6%-36%) and 71% (60%-82%) respectively 
in males, and 23% (3%-43%), 13% (0%-31%) and 64% (55%-74%) respectively in females. 
The genetic correlation between T2DM and depression was non-significant in males (0.38 (-
0.21-0.84) but significant in females (0.53 (0.19-0.98)). The significant phenotypic 







To our knowledge, this is the first study reporting a significant genetic overlap between 
T2DM and depression in females in a non-western population. Our findings in females is 
consistent with one previous report in two large Scandinavian populations (13), with most of 
the phenotypic overlap observed being due to correlated genetic factors.  Although the 
magnitude of our genetic correlation is substantially higher, the wider confidence interval 
(0.53 (0.19-0.98)) overlaps with estimates derived from the Swedish (0.23 (0.07–0.38)) and 
Danish (0.18 (0.06–0.31)) twin samples.  Our findings differ from two other twin studies 
which did not report a genetic overlap between T2DM and depression, but the effect of sex 
was not explored in these two studies (11,12). 
 
The major differences between our findings and previous reports in Western populations are 
observed for males: firstly, the phenotypic correlation was non-significant for males in our 
sample (0.06 (-0.02-0.14)), whereas it is significant in both the Swedish (male: 0.13 (0.08–
0.14), female: 0.16 (0.12-0.17)) and Danish (male: 0.16 (0.12–0.20), female: 0.15 (0.12–
0.20)) twin samples. Secondly, our best-fitting model includes the effects of common 
environment, whereas previous twin studies do not.  This might, in part, be explained by 
common environmental factors being more important in explaining individual differences in 
depression for males in non-western populations like Sri-Lanka.  The significant effects of 
common environment factors on depression have been previously reported in a Korean twin 
sample of adolescents and young adult males (32%; males (23). 
 
Our heritability estimates for depression in males were also significantly lower than those 
reported in a meta-analysis (~37%) (35).  A possible explanation is that there is more room 






leading to a lower heritability estimate.  Previous studies in the Sri-Lankan population have 
identified male-specific environmental factors to play a role in depression, namely: 
unemployment, low levels of standard of living and living in more heavily urbanised areas 
(36).  Our finding of significant common environmental effects in males might therefore 
reflect the differential economic and social pressures between the sexes in non-western 
populations and between western and non-western populations in general, and their 
subsequent effect on developing depression.   
 
In addition to the explanation above, it is possible that a different phenotype of depression 
might be captured when a questionnaire developed in a western context is used in a non-
western population.  A previous study using the Composite International Diagnostic 
Interview has demonstrated that the total number of depressive symptoms and pattern of 
symptoms endorsed were similar between the Sri-Lankan and Western populations (36), 
suggesting some degrees of phenotypic overlap.  A study in the UK has reported that people 
of South Asian origin were more likely to disclose somatic rather than psychological 
symptoms when screening for non-psychotic psychiatric disorders, although the extent of 
cultural variation in expressing psychological distress remains unclear and controversial (37).  
Given that no specific measure of environmental factors was included in our analysis, we are 
merely speculating on the nature and type of environmental factors that might contribute to 
the T2DM-depression association in non-western populations.  If our findings are replicated 
in a larger non-western population twin sample, future studies could examine whether male-
specific environmental factors modulate the aetiology of depression and its association with 
T2DM in non-western populations.  It should, however, be noted that non-western 
populations are not a uniform entity, highlighting the need to widen the current evidence base 






account in interpreting our findings: the CoTaSS-2 sample differs from previous twin studies 
in the assessment of T2DM and depression (self-report questionnaire/diagnosis versus 
clinical diagnosis derived from hospital records/registries) and being a younger cohort.  
 
Limitation  
A major limitation of the study is the reliance on self-report questionnaires for assessing 
T2DM and depression.  Information about diabetes management were unavailable at time of 
analysis, limiting the scope of cross-checking self-reported items. We did explore the use of 
HbA1c as a proxy marker for T2DM, but the phenotypic correlation with depression was very 
small in magnitude.   HbA1c is a useful clinical biomarker for assessing glycaemic status and 
guiding treatment decisions for people with T2DM. It can, however, be within the normal 
range among people with well-controlled T2DM.  For example, ~25% of individuals with 
T2DM in our study have a HbA1c <48mmol/mol (6.5%), the recommended cut-off for 
diagnosing T2DM.  HbA1c alone might therefore not be a sufficiently reliable tool for 
recognising T2DM, especially during the early stages of the disease. In addition, being 
diagnosed with T2DM, initiating and implementing the associated diabetes self-management 
might have a greater impact on the development of depression than HbA1c alone, explaining 
the differential phenotypic correlations between depression and i) T2DM diagnosis and ii) 
HbA1c.   
 
For depression, the BDI captures depressive symptoms for the past two weeks and is not 
aimed to establish a diagnosis of major depressive disorder.  The main rationale of selecting 
BDI as an outcome measure for depression in this study is its high internal consistency in 
both psychiatric and nonpsychiatric samples, rendering it appropriate for CoTaSS-2, a 






other rating scales for depression and discriminated reliably between individual with and 
without depressive symptoms (38,39).  Psychiatric disorders remain under-recognised in Sri-
Lanka.  A scarcity of mental health resources and stigma have been identified as major 
barriers for communities to seek care (40).  A recent national survey of self-reported health in 
Sri Lanka reported that only 23% of individuals reporting to have a mental illness receive any 
treatment (41).  In addition, the self-report nature of a questionnaire can affect its results due 
to social desirability and respondent educational attainment (42).  Thus, a more 
comprehensive approach would be to conduct structured diagnostic interview to screen for 
mental illnesses in the CoTASS-2 sample, but it is both time and labour intensive. 
 
Information about antidepressant was also not available at time of analysis, and thus, it is 
possible that individuals who were actively depressed and receiving antidepressant treatment 
were included in the COTASS-2 sample. This can potentially affect their responses on the 
BDI.  To further complicate the picture, mixed results have previously been reported between 
the association between antidepressants and glycaemic control.  For example, a cross-
sectional study using a large representative population of US adults without a diagnosis of 
diabetes (n=6,141) concluded that antidepressant use was not associated with an increased 
risk of abnormalities in glycaemic control or undetected diabetes (43).  A longitudinal study 
in adults who were at high risk for developing T2DM, however, demonstrated that 
antidepressant use is associated with elevated inflammatory markers and incident T2DM 
(n=3,187) (44).  The association between antidepressants use and T2DM have not been 
extensively examined in non-Western populations, and thus, the effect of antidepressants on 
HbA1c remains uncertain in the Sri-Lankan population.   
 






interview for depression or cross-validating our measures with a clinical diagnosis and 
medication registry, could potentially strengthen our finding.  Our study also utilises cross-
sectional data, and thus, we cannot determine the extent by which individuals later develop 
depression or T2DM after being recruited into the study. A longitudinal design will allow us 
to examine changes in genetic and environmental influences in the clinical course of T2DM.  
Lastly, limitations of the classical twin model apply, namely the equal environment 
assumption and the assumption of negligible correlations between the A, C and E factors 
(45).  In addition, it is important to note that the heritability estimates derived from GWAS 
using techniques such as genome-wide complex trait analysis and linkage disequilibrium 
score regression are generally half when compared to twin studies (46).  The discrepancy 
currently remains unclear and can in part be due to GWAS only capturing effects of single 
nucleotide polymorphisms with a minor allele frequency of greater than 1%. Genome-wide 
complex trait analysis also does not include non-additive interactions, such as gene-gene or 
gene-environment.  At this stage, we have only begun to uncover the complex genetic 
underpinning of the T2DM-depression association.   
 
Conclusion 
Our study strengthens previous reports of genetic factors playing an important role in the 
mechanism underlying the T2DM-depression link in females by replicating the finding in a 
non-western population and thus, demonstrating the generalizability of the finding. The 
reason for the discrepancy in findings between twin and GWAS studies is currently unclear 
and it appears that we have only begun to uncover the complex genetic underpinning of the 
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Figure 1. Venn diagram of participants with self-reported presence/absence of type 2 
diabetes (T2DM) and for whom biological samples were available. 
 
Figure 2. Parameter estimates of the bivariate ACE twin model for type 2 diabetes and 
depression. 
  
The diagram above is for best-fit sex-limitation bivariate ACE model for opposite-sex twin 
pairs. Factor notation: A indicates addictive genetic effects, C common environmental 
effects, and E unique environmental effects; subscript DM indicates type 2 diabetes and D 














































































Table 1. Descriptive statistics of monozygotic and dizygotic twins, stratified by sex. 
 
  
  Males Females 
Number of paired twins 









 Opposite-sex 543 
1 
 
Age, Mean (SD) MZ 38.2 (12.3) 39.7 (12.7) 
 DZ 40.0 (12.8) 43.0 (14.0) 
 Opposite-sex 40.7 (13.0)  
BMI, Mean (SD) MZ 22.9 (4.3) 23.8 (4.6) 
(kg/m2) DZ 22.7 (4.0) 24.3 (4.7) 
 Opposite-sex 23.7 (4.6)  
Number of T2DM cases MZ 40 51 
DZ 32 61 
Opposite-sex 82  
Fasting plasma glucose, Mean (SD) MZ 5.6 (1.6) 5.8 (2.5) 
(mmol)/l DZ 5.8 (1.7) 6.1 (2.7) 
 Opposite-sex 5.9 (2.1)  
HbA1c, Mean (SD)  
(IFCC: mmol/mol; DCTT: %) 








 Opposite-sex 41.0 (14.2) 
5.9 (1.3) 
 
Beck Depression Inventory, Mean (SD) MZ 3.7 (5.2) 4.6 (5.7) 
 DZ 3.8 (5.5) 5.1 (6.1) 







MZ: Monozygotic twins; DZ: dizygotic twins; SD: Standard deviation; BMI: body mass index; T2DM: type 2 
diabetes; IFCC: International Federation of Clinical Chemistry units; DCTT: Diabetes Control and 
Complications Trial units 
   
Proband wise concordance rate for T2DM 
(Number of concordant pair,  

















Table 2.  Correlations for i) type 2 diabetes, ii) depression and iii) type 2 diabetes– depression by 
zygosity and sex. 
 
 





  Males Females 
Within Trait Cross Twin   
T2DM MZ 0.94 (0.82-0.98) 0.85 (0.70-0.94) 
 DZ 0.44 (-0.03-0.76) 0.35 (0.01-0.62) 
 Opposite-sex 0.44 (0.16-0.65)  
Depression MZ  0.29 (0.15-0.41) 0.36 (0.25-0.45) 
 DZ 0.24 (0.08-0.38) 0.22 (0.07-0.34) 
 Opposite-sex  0.12 (0.01-0.22)  
Cross Trait Cross Twin   
T2DM - depression MZ 0.12 (0-0.25) 0.21 (0.09-0.32) 
 DZ 0.06 (-0.14-0.25) 0.06 (-0.09-0.21) 
 Opposite-sex -0.12 (-0.25-0.01)  
AC
CE
PT
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